Geriatric Medicines Market Revenue 2025 to 2034
Geriatric Medicines Market Revenue 2025 to 2034
Geriatric Medicines Market (By Therapeutics: Analgesic, Antihypertensive, Statins, Antidiabetic, PPI, Anticoagulant, Antipsychotic, Others; By Condition: Cardiovascular, Arthritis, Neurological, Cancer, Osteoporosis, Respiratory, Others; By Distribution Channel: Hospital Pharmacies, Online Pharmacies, Retail Pharmacies; By Route of Administration: Oral, Parenteral, Others; By Region: North America, Asia Pacific, Europe, Latin America, Middle East & Africa) – Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2025 to 2034.
Customisation Request
Revenue, 2025
USD 181.72 Bn
Forecast Year, 2034
USD 348.40 Bn
CAGR, 2025 - 2034
7.50%
Report Coverage
Worldwide
Published By
Saurabh Bidwai
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
The global geriatric medicines market is experiencing steady expansion, driven by the rising elderly population and increasing prevalence of age-related chronic diseases. Valued at USD 181.72 billion in 2025, the market is expected to reach USD 348.40 billion by 2034, growing at a CAGR of 7.50%.
Geriatric Medicines Market Size Analysis
Geriatric Medicines Market Size By Therapeutics 2025 to 2034 (USD Billion)
| Therapeutics | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Analgesic | 29.08 | 31.26 | 33.60 | 36.12 | 38.83 | 41.74 | 44.87 | 48.24 | 51.85 | 55.74 |
| Antihypertensive | 32.71 | 35.16 | 37.80 | 40.64 | 43.68 | 46.96 | 50.48 | 54.27 | 58.34 | 62.71 |
| Statins | 25.44 | 27.35 | 29.40 | 31.61 | 33.98 | 36.52 | 39.26 | 42.21 | 45.37 | 48.78 |
| Antidiabetic | 30.89 | 33.21 | 35.70 | 38.38 | 41.26 | 44.35 | 47.68 | 51.25 | 55.10 | 59.23 |
| PPI | 18.17 | 19.53 | 21.00 | 22.58 | 24.27 | 26.09 | 28.04 | 30.15 | 32.41 | 34.84 |
| Anticoagulant | 19.99 | 21.49 | 23.10 | 24.83 | 26.69 | 28.70 | 30.85 | 33.16 | 35.65 | 38.32 |
| Antipsychotic | 14.54 | 15.63 | 16.80 | 18.06 | 19.41 | 20.87 | 22.44 | 24.12 | 25.93 | 27.87 |
| Others | 10.90 | 11.72 | 12.60 | 13.55 | 14.56 | 15.65 | 16.83 | 18.09 | 19.45 | 20.90 |
Geriatric Medicines Market Size By Condition 2025 to 2034 (USD Billion)
| Condition | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular | 47.25 | 50.79 | 54.60 | 58.70 | 63.10 | 67.83 | 72.92 | 78.39 | 84.26 | 90.58 |
| Arthritis | 32.71 | 35.16 | 37.80 | 40.64 | 43.68 | 46.96 | 50.48 | 54.27 | 58.34 | 62.71 |
| Neurological | 25.44 | 27.35 | 29.40 | 31.61 | 33.98 | 36.52 | 39.26 | 42.21 | 45.37 | 48.78 |
| Cancer | 23.62 | 25.40 | 27.30 | 29.35 | 31.55 | 33.91 | 36.46 | 39.19 | 42.13 | 45.29 |
| Osteoporosis | 19.99 | 21.49 | 23.10 | 24.83 | 26.69 | 28.70 | 30.85 | 33.16 | 35.65 | 38.32 |
| Respiratory | 18.17 | 19.53 | 21.00 | 22.58 | 24.27 | 26.09 | 28.04 | 30.15 | 32.41 | 34.84 |
| Others | 14.54 | 15.63 | 16.80 | 18.06 | 19.41 | 20.87 | 22.44 | 24.12 | 25.93 | 27.87 |
Geriatric Medicines Market Size By Distribution Channels 2025 to 2034 (USD Billion)
| Distribution Channels | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 76.32 | 82.05 | 88.20 | 94.82 | 101.93 | 109.57 | 117.79 | 126.62 | 136.12 | 146.33 |
| Online Pharmacies | 32.71 | 35.16 | 37.80 | 40.64 | 43.68 | 46.96 | 50.48 | 54.27 | 58.34 | 62.71 |
| Retail Pharmacies | 72.69 | 78.14 | 84.00 | 90.30 | 97.07 | 104.35 | 112.18 | 120.59 | 129.64 | 139.36 |
Geriatric Medicines Market Size By Route of Administration 2025 to 2034 (USD Billion)
| Route of Administration | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| Oral | 116.30 | 125.02 | 134.40 | 144.48 | 155.32 | 166.96 | 179.49 | 192.95 | 207.42 | 222.98 |
| Parenteral | 47.25 | 50.79 | 54.60 | 58.70 | 63.10 | 67.83 | 72.92 | 78.39 | 84.26 | 90.58 |
| Others | 18.17 | 19.53 | 21.00 | 22.58 | 24.27 | 26.09 | 28.04 | 30.15 | 32.41 | 34.84 |
Geriatric Medicines Market Size By Region 2025 to 2034 (USD Billion)
| Region | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|
| North America | 61.78 | 66.42 | 71.40 | 76.76 | 82.51 | 88.70 | 95.35 | 102.50 | 110.19 | 118.46 |
| Asia Pacific | 50.88 | 54.70 | 58.80 | 63.21 | 67.95 | 73.05 | 78.53 | 84.42 | 90.75 | 97.55 |
| Europe | 39.98 | 42.98 | 46.20 | 49.67 | 53.39 | 57.39 | 61.70 | 66.33 | 71.30 | 76.65 |
| Latin America | 16.35 | 17.58 | 18.90 | 20.32 | 21.84 | 23.48 | 25.24 | 27.13 | 29.17 | 31.36 |
| Middle East and Africa | 12.72 | 13.67 | 14.70 | 15.80 | 16.99 | 18.26 | 19.63 | 21.10 | 22.69 | 24.39 |
Geriatric Medicines Market Size to Reach USD 348.40 Billion by 2034
The global geriatric medicines market size was estimated at USD 181.72 billion in 2025 and is projected to be worth around USD 348.40 billion by 2034 with a CAGR of 7.50% .
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
